Anduril IPO before 2027?

This is an interesting one... A company that just closed a massive private funding round at a sharply higher valuation has, by definition, just removed the primary financial pressure that typically forces a private company toward public markets — capital need. That mechanical relationship between funding rounds and IPO timing is the central dynamic shaping this contract, independent of anything the company's leadership says publicly about long-term intentions. The distinction between stated intent and near-term timing matters enormously here. Anduril's founder has been consistently clear that going public is the eventual destination, not an open question — but "definitely, eventually" and "before a specific near-term date" are different commitments entirely. Companies frequently signal strong eventual IPO intent while deliberately delaying the actual process to build scale, mature their contract base, or simply because there's no pressing need once a large private raise has refilled the balance sheet. The absence of any S-1 filing or registration statement as of the current snapshot reinforces that read. IPO processes have observable mechanical steps — filing, roadshow, pricing — and skipping straight from "no filing" to "public before a near-term deadline" within a compressed window is mechanically difficult even when a company wants to move fast. Companies typically need months between initial filing and actual listing. The defense and government-contracting sector adds its own texture — companies in this space often value the reduced disclosure requirements and operational flexibility of staying private longer than typical venture-backed companies, particularly while scaling sensitive government contract relationships. Bottom line: Fresh capital plus no current filing process strongly favors "stays private" as the base case. Watch for any S-1 filing announcement specifically — that's the discrete, unambiguous event that would flip this contract's entire risk profile, not general IPO speculation or executive commentary.